[Federal Register: March 13, 2003 (Volume 68, Number 49)]
[Notices]               
[Page 12089-12090]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13mr03-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

 
National Institutes of Health; National Heart, Lung, and Blood 
Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 12090]]

amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set foth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Small Business Innovative Research.
    Date: March 19, 2003.
    Time: 1 p.m. to 3:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Zoe E Huang, MD, Scientific Review 
Administrator, Review Branch, Room 7190, eivision of Extramural 
Affairs, National Heart, Lung, and Blood Institute, National 
Institutes of Health, 6701 Rockledge Drive, MSC 7924, Bethesda, MD 
20892-7924, (301) 435-0314.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93,839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS.)

    Dated: March 6, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-5979 Filed 3-12-03; 8:45 am]

BILLING CODE 4140-01-M